Celularity Stock Price Patterns
| CELUW Stock | USD 0.01 0.01 48.90% |
Momentum 45
Impartial
Oversold | Overbought |
Using Celularity hype-based prediction, you can estimate the value of Celularity from the perspective of Celularity response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Celularity to buy its stock at a price that has no basis in reality. In that case, they are not buying Celularity because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Celularity after-hype prediction price | USD 0.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Celularity | Build AI portfolio with Celularity Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Celularity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Celularity After-Hype Price Density Analysis
As far as predicting the price of Celularity at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Celularity or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Celularity, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Celularity Estimiated After-Hype Price Volatility
In the context of predicting Celularity's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Celularity's historical news coverage. Celularity's after-hype downside and upside margins for the prediction period are 0.00 and 16.21, respectively. We have considered Celularity's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Celularity is out of control at this time. Analysis and calculation of next after-hype price of Celularity is based on 3 months time horizon.
Celularity Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Celularity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Celularity backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Celularity, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.50 | 16.20 | 0.03 | 0.03 | 8 Events / Month | 4 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.01 | 7.53 |
|
Celularity Hype Timeline
Celularity is currently traded for 0.01. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.03. Celularity is anticipated to increase in value after the next headline, with the price projected to jump to 0.01 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 7.53%, whereas the daily expected return is currently at -0.5%. The volatility of related hype on Celularity is about 27208.6%, with the expected price after the next announcement by competition of 0.04. The company has Profit Margin (PM) of (1.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.43) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.43. Assuming the 90 days horizon the next anticipated press release will be in about 8 days. Check out Celularity Basic Forecasting Models to cross-verify your projections.Celularity Related Hype Analysis
Having access to credible news sources related to Celularity's direct competition is more important than ever and may enhance your ability to predict Celularity's future price movements. Getting to know how Celularity's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Celularity may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HEPA | Hepion Pharmaceuticals | 0.01 | 7 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XAGE | Longevity Health Holdings | (0.13) | 10 per month | 0.00 | (0.06) | 18.75 | (20.45) | 46.80 | |
| LIXT | Lixte Biotechnology Holdings | 0.25 | 8 per month | 0.00 | (0.03) | 7.71 | (7.45) | 19.11 | |
| IVF | INVO Fertility | 0.08 | 11 per month | 9.72 | 0 | 17.34 | (16.50) | 218.36 | |
| SISI | Shineco | 0.05 | 14 per month | 14.08 | 0.01 | 42.86 | (36.67) | 114.83 | |
| PTPI | Petros Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.13) | 12.50 | (14.29) | 55.00 | |
| SYRA | Syra Health Corp | 0.34 | 9 per month | 6.02 | 0.06 | 19.66 | (11.87) | 36.75 | |
| PKBO | Ignyte Acquisition Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OCEA | Ocean Biomedical | 0.00 | 0 per month | 30.09 | 0.22 | 166.67 | (60.00) | 473.33 | |
| PETV | PetVivo Holdings | 0.00 | 0 per month | 0.00 | (0.06) | 7.55 | (9.77) | 32.58 |
Celularity Additional Predictive Modules
Most predictive techniques to examine Celularity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Celularity using various technical indicators. When you analyze Celularity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Celularity Predictive Indicators
The successful prediction of Celularity stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Celularity, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Celularity based on analysis of Celularity hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Celularity's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Celularity's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.